ITRMF · Iterum Therapeutics plc · Analyst Estimates
$0.03
+0.01 (+34.78%)
At close · Jul 21
Return incl. dividend (before tax)
Q3 2025 earnings call transcript
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“This condition raises substantial doubt about the Company's ability to continue as a going concern for one year from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Nov 14, 2025
Market Cap
$446
Shares
44.66M
Volume · Jul 21
18.8K
Avg daily vol (3M)
99.9K
Analyst Estimates
Compare analyst forecasts for Iterum Therapeutics plc across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 07:57 UTC · Publication dates shown per estimate · 7 metric / period groups
FY ending 2025-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.73
|
-0.73
|
-0.73
|
1
|
-0.66
|
-0.66
|
-0.66
|
-0.66
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
800,000.00
|
800,000.00
|
800,000.00
|
1
|
— | — | — | — | — | — | — | — |
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.24
|
-0.24
|
-0.24
|
1
|
-0.31
|
-0.31
|
-0.31
|
-0.31
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
10.00M
|
10.00M
|
10.00M
|
1
|
— | — | — | — | — | — | — | — |
Q ending 2025-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.20
|
-0.20
|
-0.20
|
1
|
-0.15
|
-0.15
|
-0.15
|
-0.15
|
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
410,000.00
|
410,000.00
|
410,000.00
|
1
|
— | — | — | — | — | — | — | — |
Q ending 2026-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
Publication date not stated |
0.00
|
0.00
|
0.00
|
0
|
— | — | — | — | — | — | — | — |